We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Buys

Rank Stock Value
1
COLD icon
Americold
COLD
+$166M
2
OHI icon
Omega Healthcare
OHI
+$102M
3
SUI icon
Sun Communities
SUI
+$98.2M
4
AIRC
Apartment Income REIT Corp.
AIRC
+$97.3M
5
DOC icon
Healthpeak Properties
DOC
+$93.5M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLT
1151
DELISTED
Applied Therapeutics
APLT
$1K ﹤0.01%
+42
New +$875
ARDX icon
1152
Ardelyx
ARDX
$1.25B
$1K ﹤0.01%
196
-298
-60% -$1.77K
AUTL
1153
Autolus Therapeutics
AUTL
$383M
$1K ﹤0.01%
74
-94
-56% -$1K
AVDL
1154
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
+120
New +$751
CABA icon
1155
Cabaletta Bio
CABA
$435M
$1K ﹤0.01%
+45
New +$584
CLLS
1156
Cellectis
CLLS
$289M
$1K ﹤0.01%
40
-60
-60% -$1.35K
CRNX icon
1157
Crinetics Pharmaceuticals
CRNX
$8.88B
$1K ﹤0.01%
+62
New +$864
CTMX icon
1158
CytomX Therapeutics
CTMX
$699M
$1K ﹤0.01%
102
-183
-64% -$1.31K
DBC icon
1159
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$1K ﹤0.01%
100
– –
DNTH icon
1160
Dianthus Therapeutics
DNTH
$5.71B
$1K ﹤0.01%
7
-7
-50% -$794
DTIL icon
1161
Precision BioSciences
DTIL
$176M
$1K ﹤0.01%
4
-6
-60% -$1.47K
ESPR
1162
DELISTED
Esperion Therapeutics
ESPR
$1K ﹤0.01%
52
-102
-66% -$3.06K
FULC icon
1163
Fulcrum Therapeutics
FULC
$246M
$1K ﹤0.01%
+52
New +$588
GERN icon
1164
Geron
GERN
$911M
$1K ﹤0.01%
684
-1,067
-61% -$1.94K
LKFT
1165
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$1K ﹤0.01%
13
-27
-68% -$3.3K
GOSS icon
1166
Gossamer Bio
GOSS
$98.3M
$1K ﹤0.01%
143
-289
-67% -$2.85K
IDYA icon
1167
IDEAYA Biosciences
IDYA
$3.44B
$1K ﹤0.01%
+55
New +$745
NBP
1168
NovaBridge Biosciences American Depositary Shares
NBP
$189M
$1K ﹤0.01%
+30
New +$1.18K
IMUX icon
1169
Immunic
IMUX
$180M
$1K ﹤0.01%
+4
New +$718
INZY
1170
DELISTED
Inozyme Pharma
INZY
$1K ﹤0.01%
+44
New +$1.05K
KALA icon
1171
KALA BIO
KALA
$12.9M
– –
0
– –
KALV
1172
DELISTED
KalVista Pharmaceuticals
KALV
$1K ﹤0.01%
+34
New +$583
KMDA icon
1173
Kamada
KMDA
$408M
$1K ﹤0.01%
+84
New +$597
KNSA icon
1174
Kiniksa Pharmaceuticals
KNSA
$6.26B
$1K ﹤0.01%
+60
New +$1.05K
LEGN icon
1175
Legend Biotech
LEGN
$3.65B
$1K ﹤0.01%
+40
New +$1.15K
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.